151 related articles for article (PubMed ID: 33657523)
1. Inhibition of hypoxia inducible factor 1 by YC-1 attenuates tissue plasminogen activator induced hemorrhagic transformation by suppressing HMGB1/TLR4/NF-κB mediated neutrophil infiltration in thromboembolic stroke rats.
Kong L; Ma Y; Wang Z; Liu N; Ma G; Liu C; Shi R; Du G
Int Immunopharmacol; 2021 May; 94():107507. PubMed ID: 33657523
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of HIF-1 inhibition by YC-1 on the overall outcome and blood-brain barrier damage in a rat model of ischemic stroke.
Yan J; Zhou B; Taheri S; Shi H
PLoS One; 2011; 6(11):e27798. PubMed ID: 22110762
[TBL] [Abstract][Full Text] [Related]
3. Phthalide derivative CD21 attenuates tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke by enhancing macrophage scavenger receptor 1-mediated DAMP (peroxiredoxin 1) clearance.
Liu DL; Hong Z; Li JY; Yang YX; Chen C; Du JR
J Neuroinflammation; 2021 Jun; 18(1):143. PubMed ID: 34162400
[TBL] [Abstract][Full Text] [Related]
4. Glycyrrhizin Prevents Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke with Delayed Thrombolysis Through Targeting Peroxynitrite-Mediated HMGB1 Signaling.
Chen H; Guan B; Wang B; Pu H; Bai X; Chen X; Liu J; Li C; Qiu J; Yang D; Liu K; Wang Q; Qi S; Shen J
Transl Stroke Res; 2020 Oct; 11(5):967-982. PubMed ID: 31872339
[TBL] [Abstract][Full Text] [Related]
5. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO
Chen H; Guan B; Chen X; Chen X; Li C; Qiu J; Yang D; Liu KJ; Qi S; Shen J
Transl Stroke Res; 2018 Oct; 9(5):515-529. PubMed ID: 29275501
[TBL] [Abstract][Full Text] [Related]
6. LOX-1 and MMP-9 Inhibition Attenuates the Detrimental Effects of Delayed rt-PA Therapy and Improves Outcomes After Acute Ischemic Stroke.
Arkelius K; Wendt TS; Andersson H; Arnou A; Gottschalk M; Gonzales RJ; Ansar S
Circ Res; 2024 Apr; 134(8):954-969. PubMed ID: 38501247
[TBL] [Abstract][Full Text] [Related]
7. Suppression of NLRP3 attenuates hemorrhagic transformation after delayed rtPA treatment in thromboembolic stroke rats: Involvement of neutrophil recruitment.
Guo Z; Yu S; Chen X; Zheng P; Hu T; Duan Z; Liu X; Liu Q; Ye R; Zhu W; Liu X
Brain Res Bull; 2018 Mar; 137():229-240. PubMed ID: 29258866
[TBL] [Abstract][Full Text] [Related]
8. Pinocembrin attenuates hemorrhagic transformation after delayed t-PA treatment in thromboembolic stroke rats by regulating endogenous metabolites.
Kong LL; Gao L; Wang KX; Liu NN; Liu CD; Ma GD; Yang HG; Qin XM; Du GH
Acta Pharmacol Sin; 2021 Aug; 42(8):1223-1234. PubMed ID: 33859344
[TBL] [Abstract][Full Text] [Related]
9. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
[TBL] [Abstract][Full Text] [Related]
10. Neuroinflammation in hemorrhagic transformation after tissue plasminogen activator thrombolysis: Potential mechanisms, targets, therapeutic drugs and biomarkers.
Ma G; Pan Z; Kong L; Du G
Int Immunopharmacol; 2021 Jan; 90():107216. PubMed ID: 33296780
[TBL] [Abstract][Full Text] [Related]
11. D1 receptor-mediated endogenous tPA upregulation contributes to blood-brain barrier injury after acute ischaemic stroke.
Wang Y; Wang X; Zhang X; Chen S; Sun Y; Liu W; Jin X; Zheng G
J Cell Mol Med; 2020 Aug; 24(16):9255-9266. PubMed ID: 32627929
[TBL] [Abstract][Full Text] [Related]
12. Angong Niuhuang Wan reduces hemorrhagic transformation and mortality in ischemic stroke rats with delayed thrombolysis: involvement of peroxynitrite-mediated MMP-9 activation.
Chen H; Luo Y; Tsoi B; Gu B; Qi S; Shen J
Chin Med; 2022 Apr; 17(1):51. PubMed ID: 35477576
[TBL] [Abstract][Full Text] [Related]
13. Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke.
Li M; Chen S; Shi X; Lyu C; Zhang Y; Tan M; Wang C; Zang N; Liu X; Hu Y; Shen J; Zhou L; Gu Y
J Neuroinflammation; 2018 Aug; 15(1):237. PubMed ID: 30139371
[TBL] [Abstract][Full Text] [Related]
14. Xiao-Xu-Ming decoction prevented hemorrhagic transformation induced by acute hyperglycemia through inhibiting AGE-RAGE-mediated neuroinflammation.
Liu N; Liu C; Yang Y; Ma G; Wei G; Liu S; Kong L; Du G
Pharmacol Res; 2021 Jul; 169():105650. PubMed ID: 33964468
[TBL] [Abstract][Full Text] [Related]
15. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
Jean LeBlanc N; Menet R; Picard K; Parent G; Tremblay MÈ; ElAli A
Mol Neurobiol; 2019 Sep; 56(9):6521-6538. PubMed ID: 30852795
[TBL] [Abstract][Full Text] [Related]
16. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke.
García-Culebras A; Palma-Tortosa S; Moraga A; García-Yébenes I; Durán-Laforet V; Cuartero MI; de la Parra J; Barrios-Muñoz AL; Díaz-Guzmán J; Pradillo JM; Moro MA; Lizasoain I
Stroke; 2017 Jun; 48(6):1695-1699. PubMed ID: 28428349
[TBL] [Abstract][Full Text] [Related]
17. Escin avoids hemorrhagic transformation in ischemic stroke by protecting BBB through the AMPK/Cav-1/MMP-9 pathway.
Sun X; Liu Z; Zhou L; Ma R; Zhang X; Wang T; Fu F; Wang Y
Phytomedicine; 2023 Nov; 120():155071. PubMed ID: 37716034
[TBL] [Abstract][Full Text] [Related]
18. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
Wang W; Li M; Wang Y; Li Q; Deng G; Wan J; Yang Q; Chen Q; Wang J
Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
Cai Y; Liu X; Chen W; Wang Z; Xu G; Zeng Y; Ma Y
Exp Neurol; 2015 Apr; 266():120-6. PubMed ID: 25708985
[TBL] [Abstract][Full Text] [Related]
20. [VEGF-A therapeutic target against hemorrhagic transformation after t-PA treatment].
Kanazawa M; Takahashi T; Kawamura K; Shimohata T
Rinsho Shinkeigaku; 2019 Nov; 59(11):699-706. PubMed ID: 31656268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
